STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines

Pancreatic ductal adenocarcinomas (PDACs) are highly aggressive malignancies, associated with poor clinical prognosis and limited therapeutic options. Oncogenic KRAS mutations are found in over 90% of PDACs, playing a central role in tumor progression. Global gene expression profiling of PDAC reveal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Grant, Trevor J., Mehta, Anita K., Gupta, Anamika, Sharif, Ahmad A.D., Arora, Kshitij S., Deshpande, Vikram, Ting, David T., Bardeesy, Nabeel, Ganem, Neil J., Hergovich, Alexander, Singh, Anurag
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5667982/
https://ncbi.nlm.nih.gov/pubmed/29108249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20833
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados